1
|
Major GS, Doan VK, Longoni A, Bilek MMM, Wise SG, Rnjak-Kovacina J, Yeo GC, Lim KS. Mapping the microcarrier design pathway to modernise clinical mesenchymal stromal cell expansion. Trends Biotechnol 2024:S0167-7799(24)00001-5. [PMID: 38320911 DOI: 10.1016/j.tibtech.2024.01.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 01/08/2024] [Accepted: 01/08/2024] [Indexed: 02/08/2024]
Abstract
Microcarrier expansion systems show exciting potential to revolutionise mesenchymal stromal cell (MSC)-based clinical therapies by providing an opportunity for economical large-scale expansion of donor- and patient-derived cells. The poor reproducibility and efficiency of cell expansion on commercial polystyrene microcarriers have driven the development of novel microcarriers with tuneable physical, mechanical, and cell-instructive properties. These new microcarriers show innovation toward improving cell expansion outcomes, although their limited biological characterisation and compatibility with dynamic culture systems suggest the need to realign the microcarrier design pathway. Clear headway has been made toward developing infrastructure necessary for scaling up these technologies; however, key challenges remain in characterising the wholistic effects of microcarrier properties on the biological fate and function of expanded MSCs.
Collapse
Affiliation(s)
- Gretel S Major
- School of Medical Sciences, University of Sydney, Sydney, Australia
| | - Vinh K Doan
- School of Medical Sciences, University of Sydney, Sydney, Australia
| | - Alessia Longoni
- Department of Orthopedics, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Marcela M M Bilek
- School of Biomedical Engineering, University of Sydney, Sydney, Australia; School of Physics, University of Sydney, Sydney, Australia; Charles Perkins Centre, University of Sydney, Sydney, Australia; Sydney Nano Institute, University of Sydney, Sydney, Australia
| | - Steven G Wise
- School of Medical Sciences, University of Sydney, Sydney, Australia; Charles Perkins Centre, University of Sydney, Sydney, Australia
| | - Jelena Rnjak-Kovacina
- Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia; Tyree Institute of Health Engineering, University of New South Wales, Sydney, Australia
| | - Giselle C Yeo
- Charles Perkins Centre, University of Sydney, Sydney, Australia; School of Life and Environmental Sciences, University of Sydney, Sydney, Australia.
| | - Khoon S Lim
- School of Medical Sciences, University of Sydney, Sydney, Australia; Charles Perkins Centre, University of Sydney, Sydney, Australia; Sydney Nano Institute, University of Sydney, Sydney, Australia.
| |
Collapse
|
2
|
Zhang A, Wong JKU, Redzikultsava K, Baldry M, Alavi SK, Wang Z, van Koten E, Weiss A, Bilek M, Yeo GC, Akhavan B. A cost-effective and enhanced mesenchymal stem cell expansion platform with internal plasma-activated biofunctional interfaces. Mater Today Bio 2023; 22:100727. [PMID: 37529421 PMCID: PMC10388840 DOI: 10.1016/j.mtbio.2023.100727] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2023] [Revised: 06/30/2023] [Accepted: 07/07/2023] [Indexed: 08/03/2023] Open
Abstract
Mesenchymal stem cells (MSCs) used for clinical applications require in vitro expansion to achieve therapeutically relevant numbers. However, conventional planar cell expansion approaches using tissue culture vessels are inefficient, costly, and can trigger MSC phenotypic and functional decline. Here we present a one-step dry plasma process to modify the internal surfaces of three-dimensional (3D) printed, high surface area to volume ratio (high-SA:V) porous scaffolds as platforms for stem cell expansion. To address the long-lasting challenge of uniform plasma treatment within the micrometre-sized pores of scaffolds, we developed a packed bed plasma immersion ion implantation (PBPI3) technology by which plasma is ignited inside porous materials for homogeneous surface activation. COMSOL Multiphysics simulations support our experimental data and provide insights into the role of electrical field and pressure distribution in plasma ignition. Spatial surface characterisation inside scaffolds demonstrates the homogeneity of PBPI3 activation. The PBPI3 treatment induces radical-containing chemical structures that enable the covalent attachment of biomolecules via a simple, non-toxic, single-step incubation process. We showed that PBPI3-treated scaffolds biofunctionalised with fibroblast growth factor 2 (FGF2) significantly promoted the expansion of MSCs, preserved cell phenotypic expression, and multipotency, while reducing the usage of costly growth factor supplements. This breakthrough PBPI3 technology can be applied to a wide range of 3D polymeric porous scaffolds, paving the way towards developing new biomimetic interfaces for tissue engineering and regenerative medicine.
Collapse
Affiliation(s)
- Anyu Zhang
- School of Biomedical Engineering, University of Sydney, NSW 2006, Australia
- School of Physics, University of Sydney, NSW 2006, Australia
- Sydney Nano Institute, University of Sydney, NSW 2006, Australia
| | - Johnny Kuan Un Wong
- Charles Perkins Centre, University of Sydney, NSW 2006, Australia
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia
- Sydney Nano Institute, University of Sydney, NSW 2006, Australia
| | - Katazhyna Redzikultsava
- School of Biomedical Engineering, University of Sydney, NSW 2006, Australia
- School of Physics, University of Sydney, NSW 2006, Australia
| | - Mark Baldry
- School of Biomedical Engineering, University of Sydney, NSW 2006, Australia
- School of Physics, University of Sydney, NSW 2006, Australia
- Sydney Nano Institute, University of Sydney, NSW 2006, Australia
| | - Seyedeh Kh Alavi
- School of Biomedical Engineering, University of Sydney, NSW 2006, Australia
- School of Physics, University of Sydney, NSW 2006, Australia
| | - Ziyu Wang
- Charles Perkins Centre, University of Sydney, NSW 2006, Australia
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia
| | | | - Anthony Weiss
- Charles Perkins Centre, University of Sydney, NSW 2006, Australia
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia
| | - Marcela Bilek
- School of Biomedical Engineering, University of Sydney, NSW 2006, Australia
- School of Physics, University of Sydney, NSW 2006, Australia
- Charles Perkins Centre, University of Sydney, NSW 2006, Australia
- Sydney Nano Institute, University of Sydney, NSW 2006, Australia
| | - Giselle C Yeo
- Charles Perkins Centre, University of Sydney, NSW 2006, Australia
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia
| | - Behnam Akhavan
- School of Biomedical Engineering, University of Sydney, NSW 2006, Australia
- School of Physics, University of Sydney, NSW 2006, Australia
- Sydney Nano Institute, University of Sydney, NSW 2006, Australia
- School of Engineering, University of Newcastle, Callaghan, NSW 2308, Australia
- Hunter Medical Research Institute (HMRI), Precision Medicine Program, New Lambton Heights, NSW, 2305, Australia
| |
Collapse
|
3
|
Lee SS, Vũ TT, Weiss AS, Yeo GC. Stress-induced senescence in mesenchymal stem cells: Triggers, hallmarks, and current rejuvenation approaches. Eur J Cell Biol 2023; 102:151331. [PMID: 37311287 DOI: 10.1016/j.ejcb.2023.151331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 06/04/2023] [Accepted: 06/05/2023] [Indexed: 06/15/2023] Open
Abstract
Mesenchymal stem cells (MSCs) have emerged as promising cell-based therapies in the treatment of degenerative and inflammatory conditions. However, despite accumulating evidence of the breadth of MSC functional potency, their broad clinical translation is hampered by inconsistencies in therapeutic efficacy, which is at least partly due to the phenotypic and functional heterogeneity of MSC populations as they progress towards senescence in vitro. MSC senescence, a natural response to aging and stress, gives rise to altered cellular responses and functional decline. This review describes the key regenerative properties of MSCs; summarises the main triggers, mechanisms, and consequences of MSC senescence; and discusses current cellular and extracellular strategies to delay the onset or progression of senescence, or to rejuvenate biological functions lost to senescence.
Collapse
Affiliation(s)
- Sunny Shinchen Lee
- Charles Perkins Centre, The University of Sydney, NSW 2006, Australia; School of Life and Environmental Sciences, The University of Sydney, NSW 2006, Australia
| | - Thu Thuy Vũ
- Vinmec Research Institute of Stem Cell and Gene Technology, Vinmec Healthcare System, Hanoi, Viet Nam
| | - Anthony S Weiss
- Charles Perkins Centre, The University of Sydney, NSW 2006, Australia; School of Life and Environmental Sciences, The University of Sydney, NSW 2006, Australia; Sydney Nano Institute, The University of Sydney, NSW 2006, Australia
| | - Giselle C Yeo
- Charles Perkins Centre, The University of Sydney, NSW 2006, Australia; School of Life and Environmental Sciences, The University of Sydney, NSW 2006, Australia.
| |
Collapse
|
4
|
Wong JKU, Mehta A, Vũ TT, Yeo GC. Cellular modifications and biomaterial design to improve mesenchymal stem cell transplantation. Biomater Sci 2023. [PMID: 37233031 DOI: 10.1039/d3bm00376k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Research has advanced considerably since the first clinical trial of human mesenchymal stem cells (MSCs) in the early 1990s. During this period, our understanding of MSC biology and our ability to expand and manipulate these cells have provided hope for the repair of damaged tissues due to illness or injury. MSCs have conventionally been injected systemically or locally into target tissue; however, inconsistent cell homing and engraftment efficiencies represent a major bottleneck that has led to mixed results in clinical studies. To overcome these issues, MSCs have been pre-conditioned with biomolecules, genetically altered, or surface engineered to enhance their homing and engraftment capabilities. In parallel, a variety of cell-encapsulating materials have been designed to improve cell delivery and post-transplantation survival and function. In this review, we discuss the current strategies that have been employed on cultured MSCs to improve targeted cell delivery and retention for tissue repair. We also discuss the advances in injectable and implantable biomaterial technologies that drive the success of MSC-based therapies in regenerative medicine. Multi-faceted approaches combining cellular modification and cell-instructive material design can pave the way for efficient and robust stem cell transplantation for superior therapeutic outcomes.
Collapse
Affiliation(s)
- Johnny Kuan Un Wong
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia.
- Charles Perkins Centre, University of Sydney, NSW 2006, Australia
| | - Ashish Mehta
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia.
- Charles Perkins Centre, University of Sydney, NSW 2006, Australia
| | - Thu Thủy Vũ
- Vinmec Research Institute of Stem Cell and Gene Technology, Vinmec Healthcare System, Hanoi, Vietnam
| | - Giselle C Yeo
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia.
- Charles Perkins Centre, University of Sydney, NSW 2006, Australia
| |
Collapse
|
5
|
Al Halawani A, Mithieux SM, Yeo GC, Hosseini-Beheshti E, Weiss AS. Extracellular Vesicles: Interplay with the Extracellular Matrix and Modulated Cell Responses. Int J Mol Sci 2022; 23:ijms23063389. [PMID: 35328809 PMCID: PMC8954001 DOI: 10.3390/ijms23063389] [Citation(s) in RCA: 28] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Accepted: 03/16/2022] [Indexed: 12/12/2022] Open
Abstract
The discovery that cells secrete extracellular vesicles (EVs), which carry a variety of regulatory proteins, nucleic acids, and lipids, has shed light on the sophisticated manner by which cells can communicate and accordingly function. The bioactivity of EVs is not only defined by their internal content, but also through their surface associated molecules, and the linked downstream signaling effects they elicit in target cells. The extracellular matrix (ECM) contains signaling and structural molecules that are central to tissue maintenance and repair. Recently, a subset of EVs residing within the extracellular matrix has been identified. Although some roles have been proposed for matrix-bound vesicles, their role as signaling molecules within the ECM is yet to be explored. Given the close association of EVs and the ECM, it is not surprising that EVs partly mediate repair and regeneration by modulating matrix deposition and degradation through their cellular targets. This review addresses unique EV features that allow them to interact with and navigate through the ECM, describes how their release and content is influenced by the ECM, and emphasizes the emerging role of stem-cell derived EVs in tissue repair and regeneration through their matrix-modulating properties.
Collapse
Affiliation(s)
- Aleen Al Halawani
- Charles Perkins Centre, The University of Sydney, Camperdown, NSW 2006, Australia; (A.A.H.); (S.M.M.); (G.C.Y.)
- School of Life and Environmental Sciences, The University of Sydney, Camperdown, NSW 2006, Australia
| | - Suzanne M. Mithieux
- Charles Perkins Centre, The University of Sydney, Camperdown, NSW 2006, Australia; (A.A.H.); (S.M.M.); (G.C.Y.)
- School of Life and Environmental Sciences, The University of Sydney, Camperdown, NSW 2006, Australia
| | - Giselle C. Yeo
- Charles Perkins Centre, The University of Sydney, Camperdown, NSW 2006, Australia; (A.A.H.); (S.M.M.); (G.C.Y.)
- School of Life and Environmental Sciences, The University of Sydney, Camperdown, NSW 2006, Australia
| | - Elham Hosseini-Beheshti
- School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia;
- Sydney Nano Institute, The University of Sydney, Camperdown, NSW 2006, Australia
| | - Anthony S. Weiss
- Charles Perkins Centre, The University of Sydney, Camperdown, NSW 2006, Australia; (A.A.H.); (S.M.M.); (G.C.Y.)
- School of Life and Environmental Sciences, The University of Sydney, Camperdown, NSW 2006, Australia
- Sydney Nano Institute, The University of Sydney, Camperdown, NSW 2006, Australia
- Correspondence:
| |
Collapse
|
6
|
Roohani I, Yeo GC, Mithieux SM, Weiss AS. Emerging concepts in bone repair and the premise of soft materials. Curr Opin Biotechnol 2021; 74:220-229. [PMID: 34974211 DOI: 10.1016/j.copbio.2021.12.004] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2021] [Revised: 12/10/2021] [Accepted: 12/12/2021] [Indexed: 02/07/2023]
Abstract
Human bone has a strong regenerative capacity that allows for restoration of its function and structure after damage. For degenerative bone diseases or large defects, bone regeneration requirements exceed the natural potential for self-healing, so bone grafts or bone substitute materials are required to support the regeneration of bone tissue. Compared to the plethora of endogenous bioactive molecules and cells in native bone grafts, the regenerative capacity of tissue-engineered materials is limited. The modest clinical impact of tissue-engineered strategies in this domain can be attributed to a failure to fully recognize key physical and biological events during bone healing, and to recapitulate the structure and composition of the target tissue to generate truly biomimetic grafts. This limitation has motivated the emergence of new strategies such as immunomodulation, endochondral ossification routes, engineered microtissues and hematoma regulation, and the development of advanced biomaterials including gene-activated matrices, soft microgels and hierarchically designed materials.
Collapse
Affiliation(s)
- Iman Roohani
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia; Charles Perkins Centre D17, University of Sydney, NSW 2006, Australia; Sydney Nano Institute, University of Sydney, NSW 2006, Australia
| | - Giselle C Yeo
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia; Charles Perkins Centre D17, University of Sydney, NSW 2006, Australia
| | - Suzanne M Mithieux
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia; Charles Perkins Centre D17, University of Sydney, NSW 2006, Australia
| | - Anthony S Weiss
- School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia; Charles Perkins Centre D17, University of Sydney, NSW 2006, Australia; Sydney Nano Institute, University of Sydney, NSW 2006, Australia.
| |
Collapse
|
7
|
Yeo GC, Mithieux SM, Weiss AS. Erratum to “The elastin matrix in tissue engineering and regeneration”, [Curr Opin Biomed Eng, Volume 6, June 2018, Pages 27–32]. Current Opinion in Biomedical Engineering 2021. [DOI: 10.1016/j.cobme.2021.100267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
8
|
Wong KU, Zhang A, Akhavan B, Bilek MM, Yeo GC. Biomimetic Culture Strategies for the Clinical Expansion of Mesenchymal Stromal Cells. ACS Biomater Sci Eng 2021. [PMID: 33599471 DOI: 10.1021/acsbiomaterials.0c01538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Mesenchymal stromal/stem cells (MSCs) typically require significant ex vivo expansion to achieve the high cell numbers required for research and clinical applications. However, conventional MSC culture on planar (2D) plastic surfaces has been shown to induce MSC senescence and decrease cell functionality over long-term proliferation, and usually, it has a high labor requirement, a high usage of reagents, and therefore, a high cost. In this Review, we describe current MSC-based therapeutic strategies and outline the important factors that need to be considered when developing next-generation cell expansion platforms. To retain the functional value of expanded MSCs, ex vivo culture systems should ideally recapitulate the components of the native stem cell microenvironment, which include soluble cues, resident cells, and the extracellular matrix substrate. We review the interplay between these stem cell niche components and their biological roles in governing MSC phenotype and functionality. We discuss current biomimetic strategies of incorporating biochemical and biophysical cues in MSC culture platforms to grow clinically relevant cell numbers while preserving cell potency and stemness. This Review summarizes the current state of MSC expansion technologies and the challenges that still need to be overcome for MSC clinical applications to be feasible and sustainable.
Collapse
Affiliation(s)
- Kuan Un Wong
- Charles Perkins Center, The University of Sydney, Sydney, New South Wales 2006, Australia.,School of Life and Environmental Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Anyu Zhang
- School of Physics, The University of Sydney, Sydney, New South Wales 2006, Australia.,School of Biomedical Engineering, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Behnam Akhavan
- School of Physics, The University of Sydney, Sydney, New South Wales 2006, Australia.,School of Biomedical Engineering, The University of Sydney, Sydney, New South Wales 2006, Australia.,The University of Sydney Nano Institute, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Marcela M Bilek
- Charles Perkins Center, The University of Sydney, Sydney, New South Wales 2006, Australia.,School of Physics, The University of Sydney, Sydney, New South Wales 2006, Australia.,School of Biomedical Engineering, The University of Sydney, Sydney, New South Wales 2006, Australia.,The University of Sydney Nano Institute, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Giselle C Yeo
- Charles Perkins Center, The University of Sydney, Sydney, New South Wales 2006, Australia.,School of Life and Environmental Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|
9
|
Bochicchio B, Yeo GC, Lee P, Emul D, Pepe A, Laezza A, Ciarfaglia N, Quaglino D, Weiss AS. Domains 12 to 16 of tropoelastin promote cell attachment and spreading through interactions with glycosaminoglycan and integrins alphaV and alpha5beta1. FEBS J 2021; 288:4024-4038. [DOI: 10.1111/febs.15702] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2020] [Revised: 12/20/2020] [Accepted: 01/04/2021] [Indexed: 11/27/2022]
Affiliation(s)
| | - Giselle C. Yeo
- Charles Perkins Centre The University of Sydney NSW Australia
- School of Life and Environmental Sciences The University of Sydney NSW Australia
| | - Pearl Lee
- Charles Perkins Centre The University of Sydney NSW Australia
- School of Life and Environmental Sciences The University of Sydney NSW Australia
| | - Deniz Emul
- Charles Perkins Centre The University of Sydney NSW Australia
- School of Life and Environmental Sciences The University of Sydney NSW Australia
| | - Antonietta Pepe
- Department of Science University of Basilicata Potenza Italy
| | - Antonio Laezza
- Department of Science University of Basilicata Potenza Italy
| | | | - Daniela Quaglino
- Department of Life Sciences University of Modena and Reggio Emilia Modena Italy
| | - Anthony S. Weiss
- Charles Perkins Centre The University of Sydney NSW Australia
- School of Life and Environmental Sciences The University of Sydney NSW Australia
- Sydney Nano Institute The University of Sydney NSW Australia
| |
Collapse
|
10
|
|
11
|
Abstract
Vascular engineering requires integrating dimensional flexibility, strength, and bioactivity to fabricate materials that enable diffusive exchange of oxygen and nutrients between cells and their environment. A recent publication (Biomaterials 2019;192:334-345) has described a new method of creating freestanding, tailorable, and biocompatible vascular constructs by coating ice scaffolds with natural or synthetic polymers.
Collapse
Affiliation(s)
- Giselle C Yeo
- Charles Perkins Centre, The University of Sydney, NSW 2006, Australia; School of Life and Environmental Sciences, The University of Sydney, NSW 2006, Australia; Bosch Institute, The University of Sydney, NSW 2006, Australia.
| |
Collapse
|
12
|
|
13
|
Tarakanova A, Yeo GC, Baldock C, Weiss AS, Buehler MJ. Tropoelastin is a Flexible Molecule that Retains its Canonical Shape. Macromol Biosci 2018; 19:e1800250. [DOI: 10.1002/mabi.201800250] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2018] [Revised: 09/03/2018] [Indexed: 11/07/2022]
Affiliation(s)
- Anna Tarakanova
- Laboratory for Atomistic and Molecular Mechanics Department of Civil and Environmental Engineering Massachusetts Institute of Technology 02139 Cambridge MA USA
| | - Giselle C. Yeo
- School of Life and Environmental Sciences The University of Sydney 2006 Sydney NSW Australia
- Charles Perkins Centre The University of Sydney 2006 Sydney NSW Australia
| | - Clair Baldock
- Wellcome Trust Centre for Cell‐Matrix Research Division of Cell Matrix Biology and Regenerative Medicine School of Biological Sciences Manchester Academic Health Science Centre The University of Manchester M13 9PL Manchester UK
| | - Anthony S. Weiss
- School of Life and Environmental Sciences The University of Sydney 2006 Sydney NSW Australia
- Charles Perkins Centre The University of Sydney 2006 Sydney NSW Australia
- Bosch Institute The University of Sydney 2006 Sydney NSW Australia
| | - Markus J. Buehler
- Laboratory for Atomistic and Molecular Mechanics Department of Civil and Environmental Engineering Massachusetts Institute of Technology 02139 Cambridge MA USA
| |
Collapse
|
14
|
Yeo GC, Kosobrodova E, Kondyurin A, McKenzie DR, Bilek MM, Weiss AS. Plasma‐Activated Substrate with a Tropoelastin Anchor for the Maintenance and Delivery of Multipotent Adult Progenitor Cells. Macromol Biosci 2018; 19:e1800233. [DOI: 10.1002/mabi.201800233] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2018] [Revised: 08/19/2018] [Indexed: 01/05/2023]
Affiliation(s)
- Giselle C. Yeo
- Charles Perkins CentreUniversity of Sydney NSW 2006 Australia
- School of Life and Environmental SciencesUniversity of Sydney NSW 2006 Australia
- Bosch InstituteUniversity of Sydney NSW 2006 Australia
- The Cooperative Research Centre for Cell Therapy ManufacturingUniversity of South Australia City West Campus Adelaide SA 5000 Australia
| | - Elena Kosobrodova
- School of PhysicsUniversity of Sydney NSW 2006 Australia
- School of AerospaceMechanical and Mechatronic EngineeringUniversity of Sydney NSW 2006 Australia
- The Cooperative Research Centre for Cell Therapy ManufacturingUniversity of South Australia City West Campus Adelaide SA 5000 Australia
| | - Alexey Kondyurin
- School of PhysicsUniversity of Sydney NSW 2006 Australia
- The Cooperative Research Centre for Cell Therapy ManufacturingUniversity of South Australia City West Campus Adelaide SA 5000 Australia
| | - David R. McKenzie
- School of PhysicsUniversity of Sydney NSW 2006 Australia
- The Cooperative Research Centre for Cell Therapy ManufacturingUniversity of South Australia City West Campus Adelaide SA 5000 Australia
| | - Marcela M. Bilek
- Charles Perkins CentreUniversity of Sydney NSW 2006 Australia
- School of PhysicsUniversity of Sydney NSW 2006 Australia
- School of AerospaceMechanical and Mechatronic EngineeringUniversity of Sydney NSW 2006 Australia
- Australian Institute of Nanoscale Science and TechnologyUniversity of Sydney NSW 2006 Australia
- The Cooperative Research Centre for Cell Therapy ManufacturingUniversity of South Australia City West Campus Adelaide SA 5000 Australia
| | - Anthony S. Weiss
- Charles Perkins CentreUniversity of Sydney NSW 2006 Australia
- School of Life and Environmental SciencesUniversity of Sydney NSW 2006 Australia
- Bosch InstituteUniversity of Sydney NSW 2006 Australia
- The Cooperative Research Centre for Cell Therapy ManufacturingUniversity of South Australia City West Campus Adelaide SA 5000 Australia
| |
Collapse
|
15
|
Abstract
Protein folding poses unique challenges for large, disordered proteins due to the low resolution of structural data accessible in experiment and on the basis of short time scales and limited sampling attainable in computation. Such molecules are uniquely suited to accelerated-sampling molecular dynamics algorithms due to a flat-energy landscape. We apply these methods to report here the folded structure in water from a fully extended chain of tropoelastin, a 698-amino acid molecular precursor to elastic fibers that confer elasticity and recoil to tissues, finding good agreement with experimental data. We then study a series of artificial and disease-related mutations, yielding molecular mechanisms to explain structural differences and variation in hierarchical assembly observed in experiment. The present model builds a framework for studying assembly and disease and yields critical insight into molecular mechanisms behind these processes. These results suggest that proteins with disordered regions are suitable candidates for characterization by this approach.
Collapse
Affiliation(s)
- Anna Tarakanova
- Laboratory for Atomistic and Molecular Mechanics, Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, MA 01239
| | - Giselle C Yeo
- School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia
- Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia
| | - Clair Baldock
- Wellcome Trust Centre for Cell-Matrix Research, Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester M13 9PT, United Kingdom
| | - Anthony S Weiss
- School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia
- Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia
- Bosch Institute, The University of Sydney, Sydney, NSW 2006, Australia
| | - Markus J Buehler
- Laboratory for Atomistic and Molecular Mechanics, Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, MA 01239;
| |
Collapse
|
16
|
|
17
|
Wakelin EA, Yeo GC, McKenzie DR, Bilek MMM, Weiss AS. Plasma ion implantation enabled bio-functionalization of PEEK improves osteoblastic activity. APL Bioeng 2018; 2:026109. [PMID: 31069306 PMCID: PMC6481719 DOI: 10.1063/1.5010346] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2017] [Accepted: 05/08/2018] [Indexed: 12/11/2022] Open
Abstract
Slow appositional growth of bone in vivo is a major problem associated with polyether ether ketone (PEEK) based orthopaedic implants. Early stage promotion of osteoblast activity, particularly bone nodule formation, would help to improve contact between PEEK implantable materials and the surrounding bone tissue. To improve interactions with bone cells, we explored here the use of plasma immersion ion implantation (PIII) treatment of PEEK to covalently immobilize biomolecules to the surface. In this study, a single step process was used to covalently immobilize tropoelastin on the surface of PIII modified PEEK through reactions with radicals generated by the treatment. Improved bioactivity was observed using the human osteoblast-like cell line, SAOS-2. Cells on surfaces that were PIII-treated or tropoelastin-coated exhibited improved attachment, spreading, proliferation, and bone nodule formation compared to cells on untreated samples. Surfaces that were both PIII-treated and tropoelastin-coated triggered the most favorable osteoblast-like responses. Surface treatment or tropoelastin coating did not alter alkaline phosphatase gene expression and activity of bound cells but did influence the expression of other bone markers including osteocalcin, osteonectin, and collagen I. We conclude that the surface modification of PEEK improves osteoblast interactions, particularly with respect to bone apposition, and enhances the orthopedic utility of PEEK.
Collapse
Affiliation(s)
- Edgar A. Wakelin
- Applied and Plasma Physics, School of Physics, The University of Sydney, NSW 2006, Australia
| | | | - David R. McKenzie
- Applied and Plasma Physics, School of Physics, The University of Sydney, NSW 2006, Australia
| | | | | |
Collapse
|
18
|
Lee P, Yeo GC, Weiss AS. A cell adhesive peptide from tropoelastin promotes sequential cell attachment and spreading via distinct receptors. FEBS J 2017; 284:2216-2230. [DOI: 10.1111/febs.14114] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2017] [Revised: 04/30/2017] [Accepted: 05/17/2017] [Indexed: 12/20/2022]
Affiliation(s)
- Pearl Lee
- School of Life and Environmental Sciences University of Sydney Australia
- Bosch Institute University of Sydney Australia
- Charles Perkins Centre University of Sydney Australia
| | - Giselle C. Yeo
- School of Life and Environmental Sciences University of Sydney Australia
- Charles Perkins Centre University of Sydney Australia
- Applied and Plasma Physics School of Physics University of Sydney Australia
| | - Anthony S. Weiss
- School of Life and Environmental Sciences University of Sydney Australia
- Bosch Institute University of Sydney Australia
- Charles Perkins Centre University of Sydney Australia
| |
Collapse
|
19
|
Landau S, Szklanny AA, Yeo GC, Shandalov Y, Kosobrodova E, Weiss AS, Levenberg S. Tropoelastin coated PLLA-PLGA scaffolds promote vascular network formation. Biomaterials 2017; 122:72-82. [DOI: 10.1016/j.biomaterials.2017.01.015] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2016] [Revised: 01/01/2017] [Accepted: 01/10/2017] [Indexed: 01/12/2023]
|
20
|
Yeo GC, Kondyurin A, Kosobrodova E, Weiss AS, Bilek MMM. A sterilizable, biocompatible, tropoelastin surface coating immobilized by energetic ion activation. J R Soc Interface 2017; 14:20160837. [PMID: 28179545 PMCID: PMC5332567 DOI: 10.1098/rsif.2016.0837] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2016] [Accepted: 01/10/2017] [Indexed: 02/05/2023] Open
Abstract
Biomimetic materials which integrate with surrounding tissues and regulate new tissue formation are attractive for tissue engineering and regenerative medicine. Plasma immersion ion-implanted (PIII) polyethersulfone (PES) provides an excellent platform for the irreversible immobilization of bioactive proteins and peptides. PIII treatment significantly improves PES wettability and results in the formation of acidic groups on the PES surface, with the highest concentration observed at 40-80 s of PIII treatment. The elastomeric protein tropoelastin can be stably adhered to PIII-treated PES in a cell-interactive conformation by tailoring the pH and salt levels of the protein-surface association conditions. Tropoelastin-coated PIII-treated PES surfaces are resistant to molecular fouling, and actively promote high levels of fibroblast adhesion and proliferation while maintaining cell morphology. Tropoelastin, unlike other extracellular matrix proteins such as fibronectin, uniquely retains full bioactivity even after medical-grade ethylene oxide sterilization. This dual approach of PIII treatment and tropoelastin cloaking allows for the stable, robust functionalization of clinically used polymer materials for directed cellular interactions.
Collapse
Affiliation(s)
- Giselle C Yeo
- School of Physics, University of Sydney, Sydney, New South Wales 2006, Australia
- Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia
- School of Life and Environmental Sciences, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Alexey Kondyurin
- School of Physics, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Elena Kosobrodova
- School of Physics, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Anthony S Weiss
- Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia
- School of Life and Environmental Sciences, University of Sydney, Sydney, New South Wales 2006, Australia
- Bosch Institute, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Marcela M M Bilek
- School of Physics, University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|
21
|
Wise SG, Liu H, Yeo GC, Michael PL, Chan AHP, Ngo AKY, Bilek MMM, Bao S, Weiss AS. Blended Polyurethane and Tropoelastin as a Novel Class of Biologically Interactive Elastomer. Tissue Eng Part A 2016; 22:524-33. [PMID: 26857114 DOI: 10.1089/ten.tea.2015.0409] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
Polyurethanes are versatile elastomers but suffer from biological limitations such as poor control over cell attachment and the associated disadvantages of increased fibrosis. We address this problem by presenting a novel strategy that retains elasticity while modulating biological performance. We describe a new biomaterial that comprises a blend of synthetic and natural elastomers: the biostable polyurethane Elast-Eon and the recombinant human tropoelastin protein. We demonstrate that the hybrid constructs yield a class of coblended elastomers with unique physical properties. Hybrid constructs displayed higher elasticity and linear stress-strain responses over more than threefold strain. The hybrid materials showed increased overall porosity and swelling in comparison to polyurethane alone, facilitating enhanced cellular interactions. In vitro, human dermal fibroblasts showed enhanced proliferation, while in vivo, following subcutaneous implantation in mice, hybrid scaffolds displayed a reduced fibrotic response and tunable degradation rate. To our knowledge, this is the first example of a blend of synthetic and natural elastomers and is a promising approach for generating tailored bioactive scaffolds for tissue repair.
Collapse
Affiliation(s)
- Steven G Wise
- 1 The Heart Research Institute , Sydney, Australia .,2 Sydney Medical School, University of Sydney , Sydney, Australia .,3 School of Molecular Bioscience, University of Sydney , Sydney, Australia
| | - Hongjuan Liu
- 2 Sydney Medical School, University of Sydney , Sydney, Australia .,4 Discipline of Pathology and School of Medical Science, University of Sydney , Sydney, Australia .,5 Charles Perkins Centre, University of Sydney , Sydney, Australia .,6 Bosch Institute, University of Sydney , Sydney, Australia
| | - Giselle C Yeo
- 3 School of Molecular Bioscience, University of Sydney , Sydney, Australia .,5 Charles Perkins Centre, University of Sydney , Sydney, Australia
| | - Praveesuda L Michael
- 1 The Heart Research Institute , Sydney, Australia .,2 Sydney Medical School, University of Sydney , Sydney, Australia
| | - Alex H P Chan
- 1 The Heart Research Institute , Sydney, Australia .,2 Sydney Medical School, University of Sydney , Sydney, Australia
| | - Alan K Y Ngo
- 3 School of Molecular Bioscience, University of Sydney , Sydney, Australia
| | | | - Shisan Bao
- 2 Sydney Medical School, University of Sydney , Sydney, Australia .,4 Discipline of Pathology and School of Medical Science, University of Sydney , Sydney, Australia .,5 Charles Perkins Centre, University of Sydney , Sydney, Australia .,6 Bosch Institute, University of Sydney , Sydney, Australia
| | - Anthony S Weiss
- 3 School of Molecular Bioscience, University of Sydney , Sydney, Australia .,5 Charles Perkins Centre, University of Sydney , Sydney, Australia .,6 Bosch Institute, University of Sydney , Sydney, Australia
| |
Collapse
|
22
|
Yeo GC, Santos M, Kondyurin A, Liskova J, Weiss AS, Bilek MMM. Plasma-Activated Tropoelastin Functionalization of Zirconium for Improved Bone Cell Response. ACS Biomater Sci Eng 2016; 2:662-676. [PMID: 33465866 DOI: 10.1021/acsbiomaterials.6b00049] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The mechanical strength, durability, corrosion resistance, and biocompatibility of metal alloys based on zirconium (Zr) and titanium (Ti) make them desirable materials for orthopedic implants. However, as bioinert metals, they do not actively promote bone formation and integration. Here we report a plasma coating process for improving integration of such metal implants with local bone tissue. The coating is a stable carbon-based plasma polymer layer that increased surface wettability by 28%, improved surface elasticity to the range exhibited by natural bone, and additionally covalently bound the extracellular matrix protein, tropoelastin, in an active conformation. The thus biofunctionalized material was significantly more resistant to medical-grade sterilization by steam, autoclaving or gamma-ray irradiation, retaining >60% of the adhered tropoelastin molecules and preserving full bioactivity. The interface of the coating and metal was robust so as to resist delamination during surgical insertion and in vivo deployment, and the plasma process employed was utilized to also coat the complex 3D geometries typical of orthopedic implants. Osteoblast-like osteosarcoma cells cultured on the biofunctionalized Zr surface exhibited a significant 30% increase in adhesion and up to 70% improvement in proliferation. Cells on these materials also showed significant early stage up-regulation of bone marker expression (alkaline phosphatase, 1.8 fold; osteocalcin, 1.4 fold), and sustained up-regulation of these genes (alkaline phosphatase, 1.3 fold; osteocalcin, 1.2 fold) in osteogenic conditions. In addition, alkaline phosphatase production significantly increased (2-fold) on the functionalized surfaces, whereas bone mineral deposition increased by 30% above background levels compared to bare Zr. These findings have the potential to be readily translated to the development of improved Zr and Ti-based implants for accelerated bone repair.
Collapse
Affiliation(s)
| | - Miguel Santos
- The Heart Research Institute, 7 Eliza Street, Newtown, New South Wales 2050, Australia
| | | | - Jana Liskova
- Institute of Physiology, Academy of Sciences of the Czech Republic, Národní 1009/3, Prague 14220, Czech Republic
| | | | | |
Collapse
|
23
|
Yeo GC, Tarakanova A, Baldock C, Wise SG, Buehler MJ, Weiss AS. Subtle balance of tropoelastin molecular shape and flexibility regulates dynamics and hierarchical assembly. Sci Adv 2016; 2:e1501145. [PMID: 26998516 PMCID: PMC4795673 DOI: 10.1126/sciadv.1501145] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/23/2015] [Accepted: 11/20/2015] [Indexed: 05/02/2023]
Abstract
The assembly of the tropoelastin monomer into elastin is vital for conferring elasticity on blood vessels, skin, and lungs. Tropoelastin has dual needs for flexibility and structure in self-assembly. We explore the structure-dynamics-function interplay, consider the duality of molecular order and disorder, and identify equally significant functional contributions by local and global structures. To study these organizational stratifications, we perturb a key hinge region by expressing an exon that is universally spliced out in human tropoelastins. We find a herniated nanostructure with a displaced C terminus and explain by molecular modeling that flexible helices are replaced with substantial β sheets. We see atypical higher-order cross-linking and inefficient assembly into discontinuous, thick elastic fibers. We explain this dysfunction by correlating local and global structural effects with changes in the molecule's assembly dynamics. This work has general implications for our understanding of elastomeric proteins, which balance disordered regions with defined structural modules at multiple scales for functional assembly.
Collapse
Affiliation(s)
- Giselle C. Yeo
- Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales 2006, Australia
- School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Anna Tarakanova
- Laboratory for Atomistic and Molecular Mechanics, Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - Clair Baldock
- Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK
| | - Steven G. Wise
- The Heart Research Institute, Newtown, New South Wales 2050, Australia
| | - Markus J. Buehler
- Laboratory for Atomistic and Molecular Mechanics, Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - Anthony S. Weiss
- Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales 2006, Australia
- School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales 2006, Australia
- Bosch Institute, The University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|
24
|
Abstract
The mechanical stability, elasticity, inherent bioactivity, and self-assembly properties of elastin make it a highly attractive candidate for the fabrication of versatile biomaterials. The ability to engineer specific peptide sequences derived from elastin allows the precise control of these physicochemical and organizational characteristics, and further broadens the diversity of elastin-based applications. Elastin and elastin-like peptides can also be modified or blended with other natural or synthetic moieties, including peptides, proteins, polysaccharides, and polymers, to augment existing capabilities or confer additional architectural and biofunctional features to compositionally pure materials. Elastin and elastin-based composites have been subjected to diverse fabrication processes, including heating, electrospinning, wet spinning, solvent casting, freeze-drying, and cross-linking, for the manufacture of particles, fibers, gels, tubes, sheets and films. The resulting materials can be tailored to possess specific strength, elasticity, morphology, topography, porosity, wettability, surface charge, and bioactivity. This extraordinary tunability of elastin-based constructs enables their use in a range of biomedical and tissue engineering applications such as targeted drug delivery, cell encapsulation, vascular repair, nerve regeneration, wound healing, and dermal, cartilage, bone, and dental replacement.
Collapse
Affiliation(s)
- Giselle C. Yeo
- Charles Perkins Centre, The University of Sydney, NSW 2006, Australia
- School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia
| | - Behnaz Aghaei-Ghareh-Bolagh
- Charles Perkins Centre, The University of Sydney, NSW 2006, Australia
- School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia
| | - Edwin P. Brackenreg
- Charles Perkins Centre, The University of Sydney, NSW 2006, Australia
- School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia
| | - Matti A. Hiob
- Charles Perkins Centre, The University of Sydney, NSW 2006, Australia
- School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia
| | - Pearl Lee
- Charles Perkins Centre, The University of Sydney, NSW 2006, Australia
- School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia
| | - Anthony S. Weiss
- Charles Perkins Centre, The University of Sydney, NSW 2006, Australia
- School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia
- Bosch Institute, The University of Sydney, NSW 2006, Australia
| |
Collapse
|
25
|
Wakelin EA, Fathi A, Kracica M, Yeo GC, Wise SG, Weiss AS, McCulloch DG, Dehghani F, Mckenzie DR, Bilek MMM. Mechanical Properties of Plasma Immersion Ion Implanted PEEK for Bioactivation of Medical Devices. ACS Appl Mater Interfaces 2015; 7:23029-23040. [PMID: 26366514 DOI: 10.1021/acsami.5b06395] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Plasma immersion ion implantation (PIII) is used to modify the surface properties of polyether ether ketone for biomedical applications. Modifications to the mechanical and chemical properties are characterized as a function of ion fluence (treatment time) to determine the suitability of the treated surfaces for biological applications. Young's modulus and elastic recovery were found to increase with respect to treatment time at the surface from 4.4 to 5.2 MPa and from 0.49 to 0.68, respectively. The mechanical properties varied continuously with depth, forming a graded layer where the mechanical properties returned to untreated values deep within the layer. The treated surface layer exhibited cracking under cyclical loads, associated with an increased modulus due to dehydrogenation and cross-linking; however, it did not show any sign of delamination, indicating that the modified layer is well integrated with the substrate, a critical factor for bioactive surface coatings. The oxygen concentration remained unchanged at the surface; however, in contrast to ion implanted polymers containing only carbon and hydrogen, the oxygen concentration within the treated layer was found to decrease. This effect is attributed to UV exposure and suggests that PIII treatments can modify the surface to far greater depths than previously reported. Protein immobilization on PIII treated surfaces was found to be independent of treatment time, indicating that the surface mechanical properties can be tuned for specific applications without affecting the protein coverage. Our findings on the mechanical properties demonstrate such treatments render PEEK well suited for use in orthopedic implantable devices.
Collapse
Affiliation(s)
- Edgar A Wakelin
- Applied and Plasma Physics, School of Physics, The University of Sydney , Sydney, New South Wales 2006, Australia
| | - Ali Fathi
- School of Chemical and Biomolecular Engineering, The University of Sydney , Sydney, New South Wales 2006, Australia
| | - Masturina Kracica
- School of Applied Sciences, RMIT University , GPO BOX 476, Melbourne, Victoria 3001, Australia
| | - Giselle C Yeo
- School of Molecular Bioscience, The University of Sydney , Sydney, New South Wales 2006, Australia
- Charles Perkins Centre, The University of Sydney , Sydney, New South Wales 2006, Australia
| | - Steven G Wise
- Applied Materials Group, Heart Research Institute, Newtown 2042 and Sydney Medical School, The University of Sydney , Sydney, New South Wales 2006, Australia
| | - Anthony S Weiss
- School of Molecular Bioscience, The University of Sydney , Sydney, New South Wales 2006, Australia
- Charles Perkins Centre, The University of Sydney , Sydney, New South Wales 2006, Australia
| | - Dougal G McCulloch
- School of Applied Sciences, RMIT University , GPO BOX 476, Melbourne, Victoria 3001, Australia
| | - Fariba Dehghani
- School of Chemical and Biomolecular Engineering, The University of Sydney , Sydney, New South Wales 2006, Australia
| | - David R Mckenzie
- Applied and Plasma Physics, School of Physics, The University of Sydney , Sydney, New South Wales 2006, Australia
| | - Marcela M M Bilek
- Applied and Plasma Physics, School of Physics, The University of Sydney , Sydney, New South Wales 2006, Australia
| |
Collapse
|
26
|
Yu Y, Wise SG, Michael PL, Bax DV, Yuen GSC, Hiob MA, Yeo GC, Filipe EC, Dunn LL, Chan KH, Hajian H, Celermajer DS, Weiss AS, Ng MKC. Characterization of Endothelial Progenitor Cell Interactions with Human Tropoelastin. PLoS One 2015; 10:e0131101. [PMID: 26115013 PMCID: PMC4482626 DOI: 10.1371/journal.pone.0131101] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2013] [Accepted: 05/28/2015] [Indexed: 01/23/2023] Open
Abstract
The deployment of endovascular implants such as stents in the treatment of cardiovascular disease damages the vascular endothelium, increasing the risk of thrombosis and promoting neointimal hyperplasia. The rapid restoration of a functional endothelium is known to reduce these complications. Circulating endothelial progenitor cells (EPCs) are increasingly recognized as important contributors to device re-endothelialization. Extracellular matrix proteins prominent in the vessel wall may enhance EPC-directed re-endothelialization. We examined attachment, spreading and proliferation on recombinant human tropoelastin (rhTE) and investigated the mechanism and site of interaction. EPCs attached and spread on rhTE in a dose dependent manner, reaching a maximal level of 56±3% and 54±3%, respectively. EPC proliferation on rhTE was comparable to vitronectin, fibronectin and collagen. EDTA, but not heparan sulfate or lactose, reduced EPC attachment by 81±3%, while full attachment was recovered after add-back of manganese, inferring a classical integrin-mediated interaction. Integrin αVβ3 blocking antibodies decreased EPC adhesion and spreading on rhTE by 39±3% and 56±10% respectively, demonstrating a large contribution from this specific integrin. Attachment of EPCs on N-terminal rhTE constructs N25 and N18 accounted for most of this interaction, accompanied by comparable spreading. In contrast, attachment and spreading on N10 was negligible. αVβ3 blocking antibodies reduced EPC spreading on both N25 and N18 by 45±4% and 42±14%, respectively. In conclusion, rhTE supports EPC binding via an integrin mechanism involving αVβ3. N25 and N18, but not N10 constructs of rhTE contribute to EPC binding. The regulation of EPC activity by rhTE may have implications for modulation of the vascular biocompatibility of endovascular implants.
Collapse
Affiliation(s)
- Young Yu
- Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, 2050, Australia
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
| | - Steven G. Wise
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
- School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia
- * E-mail:
| | - Praveesuda L. Michael
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
| | - Daniel V. Bax
- School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia
| | - Gloria S. C. Yuen
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
| | - Matti A. Hiob
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
- School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia
| | - Giselle C. Yeo
- School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia
| | - Elysse C. Filipe
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
| | - Louise L. Dunn
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
| | - Kim H. Chan
- Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, 2050, Australia
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
| | - Hamid Hajian
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
| | - David S. Celermajer
- Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, 2050, Australia
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
| | - Anthony S. Weiss
- School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia
- Bosch Institute, University of Sydney, Sydney, NSW, 2006, Australia
- Charles Perkins Centre, University of Sydney, Sydney, NSW, 2006, Australia
| | - Martin K. C. Ng
- Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, 2050, Australia
- The Heart Research Institute, Sydney, NSW, 2042, Australia
- Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia
| |
Collapse
|
27
|
Yeo GC, Baldock C, Wise SG, Weiss AS. A negatively charged residue stabilizes the tropoelastin N-terminal region for elastic fiber assembly. J Biol Chem 2014; 289:34815-26. [PMID: 25342751 PMCID: PMC4263881 DOI: 10.1074/jbc.m114.606772] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2014] [Revised: 10/21/2014] [Indexed: 01/16/2023] Open
Abstract
Tropoelastin is an extracellular matrix protein that assembles into elastic fibers that provide elasticity and strength to vertebrate tissues. Although the contributions of specific tropoelastin regions during each stage of elastogenesis are still not fully understood, studies predominantly recognize the central hinge/bridge and C-terminal foot as the major participants in tropoelastin assembly, with a number of interactions mediated by the abundant positively charged residues within these regions. However, much less is known about the importance of the rarely occurring negatively charged residues and the N-terminal coil region in tropoelastin assembly. The sole negatively charged residue in the first half of human tropoelastin is aspartate 72. In contrast, the same region comprises 17 positively charged residues. We mutated this aspartate residue to alanine and assessed the elastogenic capacity of this novel construct. We found that D72A tropoelastin has a decreased propensity for initial self-association, and it cross-links aberrantly into denser, less porous hydrogels with reduced swelling properties. Although the mutant can bind cells normally, it does not form elastic fibers with human dermal fibroblasts and forms fewer atypical fibers with human retinal pigmented epithelial cells. This impaired functionality is associated with conformational changes in the N-terminal region. Our results strongly point to the role of the Asp-72 site in stabilizing the N-terminal segment of human tropoelastin and the importance of this region in facilitating elastic fiber assembly.
Collapse
Affiliation(s)
- Giselle C Yeo
- From the School of Molecular Bioscience and Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Clair Baldock
- the Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom
| | - Steven G Wise
- the Heart Research Institute, Sydney, New South Wales 2042, Australia, and the Sydney Medical School and
| | - Anthony S Weiss
- From the School of Molecular Bioscience and Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia, Bosch Institute, University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|
28
|
Wise SG, Yeo GC, Hiob MA, Rnjak-Kovacina J, Kaplan DL, Ng MKC, Weiss AS. Tropoelastin: a versatile, bioactive assembly module. Acta Biomater 2014; 10:1532-41. [PMID: 23938199 DOI: 10.1016/j.actbio.2013.08.003] [Citation(s) in RCA: 82] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2013] [Revised: 07/24/2013] [Accepted: 08/01/2013] [Indexed: 12/27/2022]
Abstract
Elastin provides structural integrity, biological cues and persistent elasticity to a range of important tissues, including the vasculature and lungs. Its critical importance to normal physiology makes it a desirable component of biomaterials that seek to repair or replace these tissues. The recent availability of large quantities of the highly purified elastin monomer, tropoelastin, has allowed for a thorough characterization of the mechanical and biological mechanisms underpinning the benefits of mature elastin. While tropoelastin is a flexible molecule, a combination of optical and structural analyses has defined key regions of the molecule that directly contribute to the elastomeric properties and control the cell interactions of the protein. Insights into the structure and behavior of tropoelastin have translated into increasingly sophisticated elastin-like biomaterials, evolving from classically manufactured hydrogels and fibers to new forms, stabilized in the absence of incorporated cross-linkers. Tropoelastin is also compatible with synthetic and natural co-polymers, expanding the applications of its potential use beyond traditional elastin-rich tissues and facilitating finer control of biomaterial properties and the design of next-generation tailored bioactive materials.
Collapse
Affiliation(s)
- Steven G Wise
- The Heart Research Institute, Sydney, NSW 2042, Australia; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia; School of Molecular Bioscience, University of Sydney, Sydney, NSW 2006, Australia
| | - Giselle C Yeo
- School of Molecular Bioscience, University of Sydney, Sydney, NSW 2006, Australia
| | - Matti A Hiob
- School of Molecular Bioscience, University of Sydney, Sydney, NSW 2006, Australia; The Heart Research Institute, Sydney, NSW 2042, Australia
| | - Jelena Rnjak-Kovacina
- Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA
| | - David L Kaplan
- Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA
| | - Martin K C Ng
- The Heart Research Institute, Sydney, NSW 2042, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
| | - Anthony S Weiss
- School of Molecular Bioscience, University of Sydney, Sydney, NSW 2006, Australia; Bosch Institute, University of Sydney, Sydney, NSW 2006, Australia; Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia.
| |
Collapse
|
29
|
Yeo GC, Baldock C, Tuukkanen A, Roessle M, Dyksterhuis LB, Wise SG, Matthews J, Mithieux SM, Weiss AS. Tropoelastin bridge region positions the cell-interactive C terminus and contributes to elastic fiber assembly. Proc Natl Acad Sci U S A 2012; 109:2878-83. [PMID: 22328151 PMCID: PMC3286909 DOI: 10.1073/pnas.1111615108] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
The tropoelastin monomer undergoes stages of association by coacervation, deposition onto microfibrils, and cross-linking to form elastic fibers. Tropoelastin consists of an elastic N-terminal coil region and a cell-interactive C-terminal foot region linked together by a highly exposed bridge region. The bridge region is conveniently positioned to modulate elastic fiber assembly through association by coacervation and its proximity to dominant cross-linking domains. Tropoelastin constructs that either modify or remove the entire bridge and downstream regions were assessed for elastogenesis. These constructs focused on a single alanine substitution (R515A) and a truncation (M155n) at the highly conserved arginine 515 site that borders the bridge. Each form displayed less efficient coacervation, impaired hydrogel formation, and decreased dermal fibroblast attachment compared to wild-type tropoelastin. The R515A mutant protein additionally showed reduced elastic fiber formation upon addition to human retinal pigmented epithelium cells and dermal fibroblasts. The small-angle X-ray scattering nanostructure of the R515A mutant protein revealed greater conformational flexibility around the bridge and C-terminal regions. This increased flexibility of the R515A mutant suggests that the tropoelastin R515 residue stabilizes the structure of the bridge region, which is critical for elastic fiber assembly.
Collapse
Affiliation(s)
- Giselle C Yeo
- School of Molecular Bioscience, University of Sydney, New South Wales 2006, Australia
| | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Yeo GC, Keeley FW, Weiss AS. Coacervation of tropoelastin. Adv Colloid Interface Sci 2011; 167:94-103. [PMID: 21081222 DOI: 10.1016/j.cis.2010.10.003] [Citation(s) in RCA: 160] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2010] [Revised: 10/13/2010] [Accepted: 10/15/2010] [Indexed: 12/14/2022]
Abstract
The coacervation of tropoelastin represents the first major stage of elastic fiber assembly. The process has been modeled in vitro by numerous studies, initially with mixtures of solubilized elastin, and subsequently with synthetic elastin peptides that represent hydrophobic repeat units, isolated hydrophobic domains, segments of alternating hydrophobic and cross-linking domains, or the full-length monomer. Tropoelastin coacervation in vitro is characterized by two stages: an initial phase separation, which involves a reversible inverse temperature transition of monomer to n-mer; and maturation, which is defined by the irreversible coalescence of coacervates into large species with fibrillar structures. Coacervation is an intrinsic ability of tropoelastin. It is primarily influenced by the number, sequence, and contextual arrangement of hydrophobic domains, although hydrophilic sequences can also affect the behavior of the hydrophobic domains and thus affect coacervation. External conditions including ionic strength, pH, and temperature also directly influence the propensity of tropoelastin to self-associate. Coacervation is an endothermic, entropically-driven process driven by the cooperative interactions of hydrophobic domains following destabilization of the clathrate-like water shielding these regions. The formation of such assemblies is believed to follow a helical nucleation model of polymerization. Coacervation is closely associated with conformational transitions of the monomer, such as increased β-structures in hydrophobic domains and α-helices in cross-linking domains. Tropoelastin coacervation in vivo is thought to mainly involve the central hydrophobic domains. In addition, cell-surface glycosaminoglycans and microfibrillar proteins may regulate the process. Coacervation is essential for progression to downstream elastogenic stages, and impairment of the process can result in elastin haploinsufficiency disorders such as supravalvular aortic stenosis.
Collapse
|
31
|
Lui PS, Ching KC, Salmon YM, Choo HT, Yeo GC, Sng EH. Post-operative wound infection following gynaecological operations. Singapore Med J 1984; 25:46-7. [PMID: 6463663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|